about
Serum uric acid change and modification of blood pressure and fasting plasma glucose in an overall healthy population sample: data from the Brisighella heart study.Serum lipoprotein(a) level as long-term predictor of cardiovascular mortality in a large sample of subjects in primary cardiovascular prevention: data from the Brisighella Heart Study.Circulating Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and Arterial Stiffness in a Large Population Sample: Data From the Brisighella Heart Study.Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.Effect of pistachio on brachial artery diameter and flow-mediated dilatation: a systematic review and meta-analysis of randomized, controlled-feeding clinical studies.Food and plant bioactives for reducing cardiometabolic disease risk: an evidence based approach.Nutraceutical Effects on Glucose and Lipid Metabolism in Patients with Impaired Fasting Glucose: A Pilot, Double-Blind, Placebo-Controlled, Randomized Clinical Trial on a Combined Product.Potential role of bioactive peptides in prevention and treatment of chronic diseases: a narrative review.High serum uric acid is associated to poorly controlled blood pressure and higher arterial stiffness in hypertensive subjects.Effects of a Combined Nutraceutical on Lipid Pattern, Glucose Metabolism and Inflammatory Parameters in Moderately Hypercholesterolemic Subjects: A Double-blind, Cross-over, Randomized Clinical Trial.Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: a three-arm, double-blind, randomized clinical trial.Effect of spontaneous changes in dietary components and lipoprotein(a) levels: Data from the Brisighella Heart Study.Letter by Cicero et al Regarding Article, "Long-Term Excessive Body Weight and Adult Left Ventricular Hypertrophy Are Linked Through Later-Life Body Size and Blood Pressure: The Bogalusa Heart Study".Pharmacokinetic drug evaluation of ezetimibe + simvastatin for the treatment of hypercholesterolemia.Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic.PCSK9 induces a pro-inflammatory response in macrophages.Effect of resveratrol on blood pressure: A systematic review and meta-analysis of randomized, controlled, clinical trials.Botanicals and phytochemicals active on cognitive decline: The clinical evidence.Gene targeting for chylomicronemia syndrome: The brave new world.Commentary to: "The Effects of Coenzyme Q10 Supplementation on Blood Pressures Among Patients with Metabolic Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials".Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study.LDL-oxidation, serum uric acid, kidney function and pulse-wave velocity: Data from the Brisighella Heart Study cohort.Pericardial fat as a new independent biomarker of vascular aging.Clinical relevance of biomarkers for the identification of patients with carotid atherosclerotic plaque: Potential role and limitations of cysteine protease legumain.Correction to: Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: a three-arm, double-blind, randomized clinical trial.Questioning the Associations of ω-3 Fatty Acid Supplement Use With Cardiovascular Disease RisksSerum uric acid predicts incident metabolic syndrome in the elderly in an analysis of the Brisighella Heart StudyResveratrol effect on patients with non-alcoholic fatty liver disease: A matter of dose and treatment lengthFatty liver index is associated to pulse wave velocity in healthy subjects: Data from the Brisighella Heart StudyShort-Term Hemodynamic Effects of Modern Wheat Products Substitution in Diet with Ancient Wheat Products: A Cross-Over, Randomized Clinical TrialOptimizing Lipid Pattern by Adding a Combined Nutraceutical or Pravastatin to Fenofibrate Treatment in Hypertriglyceridemic Subjects: Single Site, Randomized, Open-Label, Post-Market Clinical InvestigationAn overview of rosuvastatin/ezetimibe association for the treatment of hypercholesterolemia and mixed dyslipidemiaAchievement of low density lipoprotein (LDL) cholesterol targets in primary and secondary prevention: Analysis of a large real practice database in ItalyA randomized Placebo-Controlled Clinical Trial to Evaluate the Medium-Term Effects of Oat Fibers on Human Health: The Beta-Glucan Effects on Lipid Profile, Glycemia and inTestinal Health (BELT) StudyShort-Term Effects of Dry Extracts of Artichokeand Berberis in Hypercholesterolemic Patients Without Cardiovascular DiseaseMetabolic effect of berberine-silymarin association: A meta-analysis of randomized, double-blind, placebo-controlled clinical trialsSevere hypercholesterolaemia in a paediatric patient with congenital analbuminaemiaArterial Stiffness, Sugar-Sweetened Beverages and Fruits Intake in a Rural Population Sample: Data from the Brisighella Heart StudyEffect of Pycnogenol on Blood Pressure: Findings From a PRISMA Compliant Systematic Review and Meta-Analysis of Randomized, Double-Blind, Placebo-Controlled, Clinical StudiesUric acid and thrombotic risk: an emerging link
P50
Q31120135-BFF420E8-6F63-46BE-8060-6FC50E09C1DCQ31123207-17FF1FEE-AD54-40CE-8B4B-679AB2BE2745Q36362512-B8DBCE0E-3146-474C-B6D5-0AF98CBED07EQ38374348-499C4784-422C-4BA0-BA1A-8C959456F0A0Q38602342-3BC8309C-7660-43C2-83EF-2F7AE9BB7226Q38679373-BB2AC7A2-627C-40C3-85D6-8CC89EB36402Q38768016-AC23F3B6-F19C-45E5-9DF8-42B8D6197D90Q38940037-E94AA8C5-1CD3-4BA8-8F5A-CC352F1D428FQ39516003-E41D9C68-2BD6-46BC-87F8-3A0F290BBBBDQ39658352-C26ADD73-DEC5-4844-8BA8-A717BB0D7A60Q42363942-76C8D320-7F98-43EE-9F10-16FEAC590864Q46824239-34BC9550-9267-452D-B7F2-C63B89C99486Q47210715-00407765-6CEB-4503-B49F-89BF14E3CDB6Q47785743-7CF36F20-8B67-42D7-BB54-A83AB9452D24Q47798603-0B545050-24DA-42A9-ABEF-25E5F3D4E46AQ48112725-12B30084-53E1-4F66-B705-3B2A3357A070Q48186015-E5085FFE-FEA0-4D4D-B596-A8C13928D201Q48554233-97A427C1-4190-4693-A1B6-660108DE8FD8Q49579946-A12AF85C-F9D6-406B-A305-D6E3CAA4F936Q49907882-E671C0AD-63BF-4067-A0A3-0EFA82AB39A2Q51259034-1B64848A-05C5-480E-A719-89DB51C1DF06Q51760071-47870835-88A3-4468-8489-9F3B4CDB2AE8Q52603972-AE70CAB2-4750-4353-A485-715F69471A90Q54189196-7405919B-DF08-41C0-8425-831B7E1C809AQ55618932-AC2F8710-B155-4847-BD3B-53F6282EC5F9Q56355734-123817D2-31FB-4E01-B0D2-AA92BC99668EQ56357913-2B123CFF-858A-4582-A4EB-782DACE77572Q56374599-4172C6AE-590F-479B-B59D-C32A97EE436FQ56374957-FD22ABD7-2E20-4ABF-AD6B-611688F9459CQ58613184-343E7343-C4BB-4CC1-A5DA-1AE7B5FDF61DQ63241325-D2E0E9EE-9D9C-4E5F-B690-2D9BA587B96BQ89613652-09979280-352F-4F81-A993-264E72CE67D3Q90017383-CF0865A0-B4C4-4BAE-B450-29C92C05B506Q90074838-81778B42-FB6C-49EC-9BB5-0F514A664FA8Q90352559-9EC1EC73-4324-4802-BD1F-CEFD57E695B4Q90994693-D4C6F20C-789B-4B4C-9AD0-6C5D14BBBB8DQ91029388-73146989-4691-43EE-87A5-FDF3461D0172Q91147424-590A616B-A00F-49EE-82ED-F9C21D9C34E7Q91433255-8B42AF20-6142-457E-9AD0-C027001EE018Q91557411-D76FA98F-06CE-4BBA-A7E0-F21FC3DA56BC
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Federica Fogacci
@ast
Federica Fogacci
@en
Federica Fogacci
@es
Federica Fogacci
@nl
Federica Fogacci
@sl
type
label
Federica Fogacci
@ast
Federica Fogacci
@en
Federica Fogacci
@es
Federica Fogacci
@nl
Federica Fogacci
@sl
prefLabel
Federica Fogacci
@ast
Federica Fogacci
@en
Federica Fogacci
@es
Federica Fogacci
@nl
Federica Fogacci
@sl
P1053
R-5931-2016
P106
P1153
57189643647
P21
P31
P3829
P3835
federica-fogacci
P496
0000-0001-7853-0042